These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25168841)

  • 61. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of diagnostic kits and reagents-a viewpoint from the industry.
    Bludau HC
    Clin Diagn Virol; 1996 May; 5(2-3):147-55. PubMed ID: 15566873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Relevancy and binding character of standards for the safety of medical devices].
    Rölleke T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):605-9. PubMed ID: 19399374
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
    Norwig J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Study on the Classification and Regulation of Medical Devices in Europe and America in IVD and the Enlightenment to Our Country].
    Guo S; Huang Y; Mu R; Li J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016; 40(4):271-4. PubMed ID: 29775523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Manufacturers' Perspective on World Health Organization Prequalification of In Vitro Diagnostics.
    Morin S; Bazarova N; Jacon P; Vella S
    Clin Infect Dis; 2018 Jan; 66(2):301-305. PubMed ID: 29020182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. European Animal Tissue Directive.
    Donawa M
    Med Device Technol; 2004; 15(1):28-31. PubMed ID: 14994636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of CE marking: is there a down side?
    Sharp IR
    Commun Dis Public Health; 2003 Dec; 6(4):355-7. PubMed ID: 15067864
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.
    Parekh BS; Kalou MB; Alemnji G; Ou CY; Gershy-Damet GM; Nkengasong JN
    Am J Clin Pathol; 2010 Oct; 134(4):573-84. PubMed ID: 20855638
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.
    Fritzler MJ; Wiik A; Tan EM; Smolen JS; McDougal JS; Chan EK; Gordon TP; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wilson M; Byrd MG; Slivka L; Koziol JA
    J Rheumatol; 2003 Nov; 30(11):2374-81. PubMed ID: 14677180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro diagnostic company recalls and medical laboratory practices: an Italian case.
    Lima-Oliveira G; Lippi G; Salvagno GL; Brocco G; Guidi GC
    Biochem Med (Zagreb); 2015; 25(2):273-8. PubMed ID: 26110040
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EU approval system leaves door open for dangerous devices.
    Cohen D
    BMJ; 2012 Oct; 345():e7173. PubMed ID: 23097554
    [No Abstract]   [Full Text] [Related]  

  • 73. EC proposal for in-vitro diagnostic medical devices Directive.
    Gutowski R
    Lancet; 1992 May; 339(8805):1360-1. PubMed ID: 1350025
    [No Abstract]   [Full Text] [Related]  

  • 74. Keeping waived tests simple.
    Clin Leadersh Manag Rev; 2004; 18(1):65-9. PubMed ID: 14968759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.
    Testa S; Meijer P; Lasne D; Mullier F
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1():71-78. PubMed ID: 36074714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Switzerland: one year's experience with new regulations and a new agency.
    Voelksen R
    Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Reduction of animal experiments in experimental drug testing].
    Behrensdorf-Nicol H; Krämer B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1173-80. PubMed ID: 25183445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Introduction to in vitro diagnostic device regulatory requirements.
    Day J
    Methods Mol Biol; 2013; 949():103-12. PubMed ID: 23329438
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Devices and the food and drug administration.
    Phillips SJ; Phillips RS
    Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.